Improving Prostate Cancer Diagnosis & Prognosis One Patient at a Time.
Diagnostic and prognostic tests for prostate cancer, providing both patients and physicians with critical information for informed treatment choices.
Dr. Daniel Mercola Awarded Prestigious EDRN Grant.
Dr. Daniel Mercola, MD, PhD, Professor of Pathology and Laboratory Medicine, University of California at Irvine, receives prestigious EDRN grant award.
The Early Detection Research Network of the National Cancer Institute supports research and development of biomarkers and technologies for the clinical application of cancer detection strategies.
Congratulations to our founder for this achievement. Contact Dr. Mercola through EDRN to learn more about his developmental research...